Our Blog Melanoma360

Featured image for “The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author”
08/09/2022

The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author

When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
Blog - Melanoma360
Podcast
Featured image for “Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag”
07/22/2022

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag

(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…
Blog - Melanoma360
Breaking News
Featured image for “2022: The State of Sunscreen in the U.S.”
07/13/2022

2022: The State of Sunscreen in the U.S.

July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…
Blog - Melanoma360
Featured image for “Sun Safety and Psychological Challenges For Melanoma Survivors”
07/13/2022

Sun Safety and Psychological Challenges For Melanoma Survivors

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…
Blog - Melanoma360
Podcast
Featured image for “Parenting While Living With Melanoma”
07/12/2022

Parenting While Living With Melanoma

by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…
Blog - Melanoma360
Friends, Family, & Caregivers
Survivor Stories
Featured image for “Survivorship: Living Well with Melanoma”
06/22/2022

Survivorship: Living Well with Melanoma

Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…
Blog - Melanoma360
Podcast
Featured image for “Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life”
06/22/2022

Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life

by Mara Klecker Steve Banks doesn’t often bring up his melanoma diagnosis during a first date, though he’s always forthright…
Blog - Melanoma360
Survivor Stories
Featured image for “Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with metastatic cutaneous melanoma”
06/06/2022

Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with metastatic cutaneous melanoma

(reprint from Biospace, published: Jun 03, 2022) Immunocore announcesclinical trial collaboration with Sanofito evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2,in combination with KIMMTRAK® in patients with metastatic cutaneous…
Blog - Melanoma360
Breaking News
Featured image for “Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II Melanoma”
06/05/2022

Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II Melanoma

(reprint from Targeted Oncology, published: Jun 05, 2022) Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II…
Blog - Melanoma360
Breaking News
Featured image for “Interview with Dr. Zeynep Eroglu, Medical Oncologist, Moffitt Cancer Center”
05/25/2022

Interview with Dr. Zeynep Eroglu, Medical Oncologist, Moffitt Cancer Center

Dr. Zeynep Eroglu is a medical oncologist at Moffitt Cancer Center in Florida. Dr. Eroglu’s research interests are translational and…
Blog - Melanoma360
Melanoma Research
08/09/2022

The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author

When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
Featured image for “The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author”
Blog - Melanoma360
 | 
Podcast
07/22/2022

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag

(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…
Featured image for “Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag”
Blog - Melanoma360
 | 
Breaking News
07/13/2022

2022: The State of Sunscreen in the U.S.

July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…
Featured image for “2022: The State of Sunscreen in the U.S.”
Blog - Melanoma360
07/13/2022

Sun Safety and Psychological Challenges For Melanoma Survivors

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…
Featured image for “Sun Safety and Psychological Challenges For Melanoma Survivors”
Blog - Melanoma360
 | 
Podcast
07/12/2022

Parenting While Living With Melanoma

by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…
Featured image for “Parenting While Living With Melanoma”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Survivor Stories
06/22/2022

Survivorship: Living Well with Melanoma

Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…
Featured image for “Survivorship: Living Well with Melanoma”
Blog - Melanoma360
 | 
Podcast
06/22/2022

Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life

by Mara Klecker Steve Banks doesn’t often bring up his melanoma diagnosis during a first date, though he’s always forthright…
Featured image for “Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life”
Blog - Melanoma360
 | 
Survivor Stories
06/06/2022

Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with metastatic cutaneous melanoma

(reprint from Biospace, published: Jun 03, 2022) Immunocore announcesclinical trial collaboration with Sanofito evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2,in combination with KIMMTRAK® in patients with metastatic cutaneous…
Featured image for “Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with metastatic cutaneous melanoma”
Blog - Melanoma360
 | 
Breaking News
06/05/2022

Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II Melanoma

(reprint from Targeted Oncology, published: Jun 05, 2022) Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II…
Featured image for “Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II Melanoma”
Blog - Melanoma360
 | 
Breaking News
05/25/2022

Interview with Dr. Zeynep Eroglu, Medical Oncologist, Moffitt Cancer Center

Dr. Zeynep Eroglu is a medical oncologist at Moffitt Cancer Center in Florida. Dr. Eroglu’s research interests are translational and…
Featured image for “Interview with Dr. Zeynep Eroglu, Medical Oncologist, Moffitt Cancer Center”
Blog - Melanoma360
 | 
Melanoma Research